These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 9074306

  • 1. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
    Lapierre YD, Joffe R, McKenna K, Bland R, Kennedy S, Ingram P, Reesal R, Rickhi BG, Beauclair L, Chouinard G, Annable L.
    J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
    [Abstract] [Full Text] [Related]

  • 2. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R.
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A, Mikkelsen H, Delini-Stula A.
    J Psychiatr Res; 1996 Jan; 30(6):453-8. PubMed ID: 9023788
    [Abstract] [Full Text] [Related]

  • 4. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S, Turkçapar MH, Ozturk Kiliç EZ, Demirergi N, Akdemir A, Sirin A, Ozbay MH.
    Acta Psychiatr Belg; 1995 Jan; 95(3):139-51. PubMed ID: 8525856
    [Abstract] [Full Text] [Related]

  • 5. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
    Stassen HH, Angst J, Delini-Stula A.
    Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
    [Abstract] [Full Text] [Related]

  • 6. Moclobemide versus fluoxetine for major depressive episodes.
    Geerts S, Bruynooghe F, De Cuyper H, Demeulemeester F, Haazen L.
    Clin Neuropharmacol; 1994 Mar; 17 Suppl 1():S50-7. PubMed ID: 7954484
    [Abstract] [Full Text] [Related]

  • 7. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L, Evrard JL, Gilles C, Stenier P, Wolfrum C.
    Acta Psychiatr Belg; 1992 Mar; 92(6):355-69. PubMed ID: 1345409
    [Abstract] [Full Text] [Related]

  • 8. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J.
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P, Baker B, Irvine J, Dorian P, McKessok D, Mendlowitz S.
    Depress Anxiety; 1998 Sep; 7(2):69-72. PubMed ID: 9614594
    [Abstract] [Full Text] [Related]

  • 10. Moclobemide versus fluoxetine for a major depressive episode.
    Reynaert C, Parent M, Mirel J, Janne P, Haazen L.
    Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
    [Abstract] [Full Text] [Related]

  • 11. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
    Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH.
    J Ethnopharmacol; 2005 Feb 28; 97(2):281-4. PubMed ID: 15707766
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 28; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 28; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan 28; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 15. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF, Lane RM, Zhu R, Ying Z.
    Int Clin Psychopharmacol; 1999 Sep 28; 14(5):259-75. PubMed ID: 10529069
    [Abstract] [Full Text] [Related]

  • 16. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J, Ryde L, Svejsø J, Lauge N, Lauritsen B, Bech P.
    Pharmacopsychiatry; 1998 Mar 28; 31(2):48-54. PubMed ID: 9562208
    [Abstract] [Full Text] [Related]

  • 17. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP, Tsoi WF.
    Singapore Med J; 1995 Feb 28; 36(1):38-40. PubMed ID: 7570133
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
    Dittmann RW, Linden M, Osterheider M, Schaaf B, Ohnmacht U, Weber HJ.
    Pharmacopsychiatry; 1997 Jan 28; 30(1 Suppl):28-34. PubMed ID: 9035225
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J.
    Int Clin Psychopharmacol; 2008 Sep 28; 23(5):269-75. PubMed ID: 18703936
    [Abstract] [Full Text] [Related]

  • 20. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP.
    J Clin Psychiatry; 1985 Sep 28; 46(9):369-72. PubMed ID: 3897204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.